Ash Crypto Says This Major Breakout Is Bullish for XRP Holders
XRP spent much of the past two months grinding lower. The token peaked at $1.54 in mid-May, followed by a sustained, structured decline for 66 days.
Crypto analyst Ash Crypto (@AshCrypto) posted a chart Tuesday showing that decline has now ended. “XRP just broke out of its 66-day downtrend,” noting that this is bullish for XRP holders.
The chart tells a clear story. A descending trendline connects a sequence of lower highs starting from the May peak near $1.54. Three separate rally attempts, each marked on the chart with yellow arrows, failed at that trendline in early June, mid-June, and early July.
Each rejection came at a lower price than the last. The pattern continued until XRP bottomed just above $1 in late June, testing a key psychological support level before stabilizing.
The June Decline
The sharpest selling pressure arrived in early June. XRP fell from around $1.38 to below $1.10 in a matter of days, a move that extended the downtrend and erased the gains from a brief recovery attempt. Buyers stepped in near $1, but rallies stayed capped below the trendline. That resistance held through three distinct tests over the following weeks.
The Breakout
The structure changed around July 21. XRP pushed above the descending trendline and held. At the time of the chart, the token traded at $1.1361. The white arrow on Ash Crypto’s chart marks the breakout candle above the trendline, a level that had rejected every prior rally attempt since May.
Trendline breaks of this kind carry significance. The break matters because long structures rarely snap without repositioning behind them. Breaking a barrier that has held for months can activate clusters of resting orders and force a rapid repricing of the asset.
What Analysts Are Watching
Multiple analysts see July as a potentially important month for XRP. Historically, XRP closed higher on the last day of July in eight out of 13 years, making it one of the best months for XRP in its history.
July still has just under two weeks remaining. Sentiment among analysts has turned constructive following the breakout, with many analysts hoping the asset will repeat history. A successful breakout above the $1.12-$1.18 resistance zone would open the way toward medium-term targets close to $1.60 and maybe higher before the month ends.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
As AI controversies escalate, hedge funds buy tech stocks at the fastest pace in 15 months
Hedge funds have recorded net purchases of US TMT stocks on 10 out of the past 11 trading days, rebuilding tech long positions at the fastest pace in 15 months. However, an AI policy storm has struck at the "worst possible time"—calls by AI giants to slow down development have been rejected, and regulatory uncertainty has directly hit Asian tech stocks such as Softbank. As the tech sector's bullish run coincides with Super Central Bank Week, the sector now faces a severe test.
Apple Pre-sale Tracker: iPhone 18 Pro Series Shows Weak Overseas Demand Signals, Duo Review Positive but Hardware Lags Behind
According to a survey by Jefferies, after the launch of the iPhone 18 Pro, delivery wait times in the four major markets—the US, UK, Germany, and Japan—have shortened by 5 to 11 days compared to last year, with no wait time in the US. Given stable production capacity, this is a clear sign of weak demand. Although the China and Hong Kong markets have performed better against the trend, there are still suspicions of speculative stockpiling. The new foldable Duo has been praised for its software experience, but its $2,000 price tag comes with a 254-gram body and dual-camera setup, leaving its hardware lagging significantly behind Android competitors. Jefferies maintains an "underperform" rating, with a target price implying a 21% downside from the current level.
SUI holds $0.71 support as analysts cite key buy signal, eyes on possible recovery
UBS Health Benefit Survey: Elevance Health (ELV.US) Leads, U.S. Employers Prepare for Rising Medical Costs
In the annual survey by UBS for employee benefits management institutions, Elevance Health (ELV.US) emerged as the highest-rated US health insurance company.

